|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
Review Article |
Laboratory of Neuro-Oncology, Department of Anatomy and Cell Biology, University of Bergen, N-5009 Bergen, Norway
2 Address correspondence and reprint requests to Therese Visted, Department of Anatomy and Cell Biology, University of Bergen 19, N-5019 Bergen, Norway.
Abstract
Gene therapy using viral vectors has to date failed to reveal its definitive clinical usefulness. Cell encapsulation technology represents an alternative, nonviral approach for the delivery of biologically active compounds to tumors. This strategy involves the use of genetically engineered producer cells that secrete a protein with therapeutic potential. The cells are encapsulated in an immunoisolating material that makes them suitable for transplantation. The capsules, or bioreactors, permit the release of recombinant proteins that may assert their effects in the tumor microenvironment. During the last decades, there has been significant progress in the development of encapsulation technologies that comprise devices for both macro- and microencapsulation. The polysaccharide alginate is the most commonly used material for cell encapsulation and is well tolerated by various tissues. A wide spectrum of cells and tissues has been encapsulated and implanted, both in animals and humans, indicating the general applicability of this approach for both research and medical purposes, including CNS malignancies. Gliomas most frequently recur at the resection site. To provide local and sustained drug delivery, the bioreactors can be implanted in the brain parenchyma or in the ventricular system. The development of comprehensive analyses of geno- and phenotypic profiles of a tumor (genomics and proteomics) may provide new and important guidelines for choosing the optimal combination of bioreactors and recombinant proteins for therapeutic use.
References
Aebischer, P., Winn, S.R., Tresco, P.A., Jaeger, C.B., and Greene, L.A. (1991) Transplantation of polymer encapsulated neurotransmitter secreting cells: Effect of the encapsulation technique. J. Biomech. Eng. 113,178 -183.[Web of Science][Medline]
Aebischer, P., Scluep, M., Deglon, N., Joseph, J.M., Hirt, L., Heyd, B., Goddard, M., Hammang, J.P., Zurn, A.D., Kato, A.C., Regli, F., and Baetge, E.E. (1996) Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat. Med. 2, 696-699.[CrossRef][Web of Science][Medline]
Bachoud-Levi, A.C., Deglon, N., Nguyen, J.P., Bloch, J., Bourdet, C., Winkel, L., Remy, P., Goddard, M., Lefaucheur, J.P., Brugieres, P., Baudic, S., Cesaro, P., Peschanski, M., and Aebischer, P. (2000) Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF. Hum. Gene Ther. 11,1723 -1729.[CrossRef][Web of Science][Medline]
Biseeglie, V. (1933) Über die antineoplastische Immunitat. Z. Krebsforsch. 40, 141.
Brem, H., Piantadosi, S., Burger, P.C., Walker, M., Selker, R., Vick, N.A., Black, K., Sisti, M., Brem, S., Mohr, G., Muller, P., Moravetz, R., and Schold, S.C. (1995) Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 345,1008 -1012.[CrossRef][Web of Science][Medline]
Buchser, E., Goddard, M., Heyd, B., Joseph, J.M., Favre, J., de Tribolet, N., Lysaght, M., and Aebischer, P. (1996) Immunoisolated xenogenic chromaffin cell therapy for chronic pain: Initial clinical experience. Anesthesiology 85,1005 -1012.[CrossRef][Web of Science][Medline]
Cherksey, B.D., Sapirstein, V.S., and Geraci, A.L. (1996) Adrenal chromaffin cells on microcarriers exhibit enhanced long-term functional effects when implanted into the mammalian brain. Neuroscience 75,657 -664.[CrossRef][Web of Science][Medline]
Chick, W.L., Perna, J.J., Lauris, V., Low, D., Galetti, P.M.,
Panol, G., Whittemore, A.D., Like, A.A., Colton, C.K., and Lysaght, M.J.
(1977) Artificial pancreas using living beta cells: Effects on
glucose hemostasis in diabetic rats. Science
197,780
-782.
Emerich, D.F., Winn, S.R., Hantraye, P.M., Peschanski, M., Chen, E.Y., Chu, Y., McDermott, P., Baetge, E.E., and Kordower, J.H. (1997) Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Nature 386,395 -399.[CrossRef][Medline]
Fung, L.K., Ewend, M.G., Sills, A., Sipos, E.P., Thompson, R.,
Watts, M., Colvin, O.M., Brem, H., and Saltzman, W.M. (1998)
Pharmacokinetics of interstitial delivery of carmustine,
4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer
implant in the monkey brain. Cancer Res.
58,672
-684.
Gossen, M., and Bujard, H. (1992) Tight control of
gene expression in mammalian cells by tetracycline-responsive promoters.
Proc. Natl. Acad. Sci. U.S.A.
89,5547
-5551.
Grant, G.T., Morris, E.R., Rees, D.A., Smith, P.J.C., and Thom, D. (1973) Biological interactions between polysaccharides and divalent cations: The egg-box model. FEBS Lett. 32,195 -198.[CrossRef]
Harsh, G.R., Deisboeck, T.S., Louis, D.N., Hilton, J., Colvin, M., Silver, J.S., Qureshi, N.H., Kracher, J., Finkelstein, D., Chiocca, E.A., and Hochberg, F.H. (2000) Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: A gene-marking and neuropathological study. J. Neurosurg. 92,804 -811.[Web of Science][Medline]
Hasse, C., Schrezenmeir, J., Stinner, B., Schark, C., Wagner, P.K., Neumann, K., and Rothmund, M. (1994) Successful allotransplantation of microencapsulated parathyroids in rats. World J. Surg. 18,630 -634.[CrossRef][Web of Science][Medline]
Hasse, C., Zielke, A., Klöck, G., Schlosser, A., Barth, P., Zimmermann, U., Sitter, H., Lorenz, W., and Rothmund, M. (1998) Amitogenic alginates: Key to first clinical application of microencapsulation technology. World J. Surg. 22,659 -665.[CrossRef][Web of Science][Medline]
Hillgärtner, M., Zimmermann, H., Mimietz, A., Jork, A., Thürmer, F., Schneider, H., Nöth, U., Hasse, C., Haase, A., Fuhr, G., Rothmund, M., and Zimmermann, U. (1999) Immunoisolation of transplants by entrapment in 19F-labelled alginate: Production, biocompatibility, stability, and long-term monitoring of functional integrity. Mat.-wiss. u. Werkstofftech. 30,783 -792.[CrossRef]
Hortelano, G., Al-Hendy, A., Ofosu, F.A., and Chang, P.L.
(1996) Delivery of human factor IX in mice by encapsulated
recombinant myoblasts: A novel approach towards allogeneic gene therapy of
hemophilia B. Blood 87,5095
-5103.
Jahr, T.G., Ryan, L., Sundan, A., Lichenstein, H.S., Skjak-Braek, G., and Espevik, T. (1997) Induction of tumor necrosis factor production from monocytes stimulated with mannuronic acid polymers and involvement of lipopolysaccharide-binding protein, CD14, and bactericidal/permeability-increasing factor. Infect. Immunol. 65,89 -94.[Abstract]
Joki, T., Machluf, M., Atala, A., Zhu, J.H., Seyfried, N.T., Dunn, I.F., Abe, T., Carroll, R.S., and Black, P.M. (2001) Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat. Biotechnol. 19, 35-39.[CrossRef][Web of Science][Medline]
Kühtreiber, W.M., Lanza, R.P., and Chick, W.L. (Eds.) (1999) Cell Encapsulation Technology and Therapeutics. Boston: Birkhäuser.
Kulseng, B., Thu, B., Espevik, T., and Skjak-Braek, G. (1997) Alginate polylysine microcapsules as immune barrier: Permeability of cytokines and immunoglobulins over the capsule membrane. Cell Transplant. 6,387 -394.[CrossRef][Web of Science][Medline]
Kulseng, B., Skjak-Braek, G., Ryan, L., Andersson, A., King, A., Faxvaag, A., and Espevik, T. (1999) Transplantation of alginate microcapsules: Generation of antibodies against alginates and encapsulated porcine islet-like cell clusters. Transplantation 67,978 -984.[CrossRef][Web of Science][Medline]
Lacy, P.E. (1995) Treating diabetes with transplanted cells. Sci. Am. 273,50 -51 and 54-58.[Web of Science][Medline]
Laham, R., Sellke, F.W., Edelman, E.R., Pearlman, J.D., Ware, J.A.,
Brown, D.L., Gold, J.P., and Simons, M. (1999) Local perivascular
delivery of basic fibroblast growth factor in patients undergoing coronary
bypass surgery: Results of a phase I randomized, double-blind,
placebo-controlled trial. Circulation
100,1865
-1871.
Lang, F.F., Fuller, G.N., Prados, M., Sawaya, R., and Yung, W.K.A. (2000) Preliminary results of a phase I clinical trial of adenovirus-mediated p53 gene therapy for recurrent glioma: Biological studies. Neuro-Oncology [serial online], Doc. 00-D129, September 21, 2000. URL: http://neuro-oncology.mc.duke.edu. Neuro-Oncology 2,277 . (Abstract)
Lanza, R.P., Kuhtreiber, W.M., Ecker, D.M., Marsh, J.P., and Chick, W.L. (1995) Transplantation of porcine and bovine islets into mice without immunosuppression using uncoated alginate microspheres. Transplant. Proc. 27,3321 . (Abstract)[Web of Science][Medline]
Lanza, R.P., Hayes, J.L., and Chick, W.L. (1996) Encapsulated cell technology. Nat. Biotechnol. 14,1107 -1111.[CrossRef][Web of Science][Medline]
Lim, F., and Sun, A.M. (1980) Microencapsulated islets
as bioartificial endocrine pancreas. Science
210,908
-910.
Lindner, M.D., Plone, M.A., Mullins, T.D., Winn, S.R., Chandonait, S.E., Stott, J.A., Blaney, T.J., Sherman, S.S., and Emerich, D.F. (1997) Somatic delivery of catecholamines in the striatum attenuate parkinsonian symptoms and widen the therapeutic window of oral sinemet in rats. Exp. Neurol. 145,130 -140.[CrossRef][Web of Science][Medline]
Løhr, M., Bago, Z.T., Bergmeister, H., Ceijna, M., Freund, M., Gelbmann, W., Gunzburg, W.H., Jesnowski, R., Hain, J., Hauenstein, K., Henninger, W., Hoffmeyer, A., Karle, P., Kroger, J.C., Kundt, G., Liebe, S., Losert, U., Muller, P., Probst, A., Punschel, K., Renner, M., Renz, R., Saller, R., Salmons, B., Schuh, M., Schwendenwein, I., von Rombs, K., Wagner, T., Walter, I. (1999) Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: A phase I/II study. J. Mol. Med. 77,393 -398.[CrossRef][Web of Science][Medline]
Marcel, T., and Grausz, J.D. (1996) The TMC worldwide gene therapy enrollment report. Hum. Gene Ther. 7,2025 -2046.[Web of Science][Medline]
Martinsen, A., Storrø, I., and Skjåk-Braek, G. (1992) Alginate as immobilization material. III. Diffusional properties. Biotechnol. Bioeng. 39,186 -194.[CrossRef]
Mitsumoto, H., Ikeda, K., Klinkosz, B., Cedarbaum, J.M., Wong, V.,
and Lindsay, R.M. (1994) Arrest of motor neuron disease in
wobbler mice cotreated with CNTF and BDNF. Science
265,1107
-1110.
Morris, E.R., Rees, D.A., and Thom, D. (1978) Chiroptical and stochiometric evidence of a specific, primary dimerisation process in alginate gelation. Carbohydr. Res. [AU: journal title/abbrev. correct?] 66,145 -154.[CrossRef]
Onsøyen, E. (1996) Commercial applications of alginates. Carbohydr. Eur. 14, 26-31.
Otterlei, M., Ostgaard, K., Skjak-Braek, G., Smidsrod, O., Soon-Shiong, P., and Espevik, T. (1991) Induction of cytokine production from human monocytes stimulated with alginate. J. Immunother. 10,286 -291.
Oyvind, P.E., Visted, T., Thorsen, F., Bjerkvig, R., and Lund-Johansen, M. (1999) Retroviral transfection of the lacZ gene from Liz-9 packaging cells to glioma spheroids. Int. J. Dev. Neurosci. 17,665 -672.[CrossRef][Web of Science][Medline]
Peirone, M., Ross, C.J., Hortelano, G., Brash, J.L., and Chang, P.L. (1998) Encapsulation of various recombinant mammalian cell types in different alginate microcapsules. J. Biomed. Mater. Res. 42,587 -596.[CrossRef][Web of Science][Medline]
Puumalainen, A.M., Vapalahti, M., Agrawal, R.S., Kossila, M., Laukkanen, J., Lehtolainen, P., Viita, H., Paljarvi, L., Vanninen, R., and Yla-Herttuala, S. (1998) Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses. Hum. Gene Ther. 9,1769 -1774.[Web of Science][Medline]
Read, T.A., Stensvaag, V., Vindenes, H., Ulvestad, E., Bjerkvig, R., and Thorsen, F. (1999) Cells encapsulated in alginate: A potential system for delivery of recombinant proteins to malignant brain tumours. Int. J. Dev. Neurosci. 17,653 -663.[CrossRef][Web of Science][Medline]
Read, T.A., Sorensen, D.R., Mahesparan, R., Enger, P.Ø., Timpl, R., Olsen, B.R., Hjelstuen, M.H.B., Haraldseth, O., and Bjerkvig, R. (2001) Local endostatin treatment of gliomas administered by microencapsulated producer cells. Nat. Biotechnol. 19, 29-34.[CrossRef][Web of Science][Medline]
Renken, A., and Hunkeler, D. (1998) Microencapsulation: A review of polymers and technologies with a focus on bioartificial organs. Polimery 43,530 -539.[Web of Science]
Ross, C.J., Ralph, M., and Chang, P.L. (1999) Delivery of recombinant gene products to the central nervous system with nonautologous cells in alginate microcapsules. Hum. Gene Ther. 10, 49-59.[CrossRef][Web of Science][Medline]
Sandmair, A.M., Loimas, S., Poptani, H., Vainio, P., Vanninen, R., Turunen, M., Tyynela, K., Vapalahti, M., and Yla-Herttuala, S. (1999) Low efficacy of gene therapy for rat BT4C malignant glioma using intra-tumoural transduction with thymidine kinase retrovirus packaging cell injections and ganciclovir treatment. Acta Neurochir. 141,867 -872.[CrossRef]
Sendtner, M., Holtmann, B., Kolbeck, R., Thoenen, H., and Barde, Y.A. (1992) Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature 360,757 -759.[CrossRef][Medline]
Siebers, U., Horcher, A., Brandhorst, H., Brandhorst, D., Hering, B., Federlin, K., Bretzel, R.G., and Zekorn, T. (1999) Analysis of the cellular reaction towards microencapsulated xenogeneic islets after intraperitoneal transplantation. J. Mol. Med. 77,215 -218.[CrossRef][Web of Science][Medline]
Skjak-Braek, G., Grasdalen, H., and Smidsrod, O. (1989) Inhomogeneous polysaccharide ionic gels. Carbohhydr. Polymers 10,31 -54.
Soon-Shiong, P., Feldman, E., Nelson, R., Komtebedde, J., Smidsrod, O., Skjak-Braek, G., Espevik, T., Heintz, R., and Lee, M. (1992) Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets. Transplantation 54,769 -774.[Web of Science][Medline]
Soon-Shiong, P., Heintz, R.E., Merideth, N., Yao, Q.X., Yao, Z., Zheng, T., Murphy, M., Moloney, M.K., Schmehl, M., Harris, M., Mendez, R., Mendez, R.G., Sanford, P.A. (1994) Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 343,950 -951.[CrossRef][Web of Science][Medline]
Tamargo, R.J., Myseros, J.S., Epstein, J.I., Yang, M.B., Chasin,
M., and Brem, H. (1993) Interstitial chemotherapy of the 9L
gliosarcoma: Controlled release polymers for drug delivery in the brain.
Cancer Res. 53,329
-333.
Thorsen, F., Read, T.A., Lund-Johansen, M., Tysnes, B.B., and Bjerkvig, R. (2000) Alginate-encapsulated producer cells: A potential new approach for the treatment of malignant brain tumors. Cell Transplant. 9,773 -783.[Web of Science][Medline]
Thu, B., Bruheim, P., Espevik, T., Smidsrod, O., Soon-Shiong, P., and Skjak-Braek, G. (1996a) Alginate polycation microcapsules. II. Some functional properties. Biomaterials 17,1069 -1079.[CrossRef][Web of Science][Medline]
Thu, B., Bruheim, P., Espevik, T., Smidsrod, O., Soon-Shiong, P., and Skjak-Braek, G. (1996b) Alginate polycation microcapsules. I. Interaction between alginate and polycation. Biomaterials 17,1031 -1040.[CrossRef][Web of Science][Medline]
Tze, W.J., and Chen, L.M. (1977) Long-term survival of adult rat islets of langerhans in artificial capillary culture units. Diabetes 26,185 -191.[Abstract]
Valtonen, S., Timonen, U., Toivanen, P., Kalimo, H., Kivipelto, L., Heiskanen, O., Unsgaard, G., and Kuurne, T. (1997) Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: A randomized double-blind study. Neurosurgery 41, 44-48.[CrossRef][Web of Science][Medline]
van Schilfgaarde, R., and de Vos, P. (1999) Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets. J. Mol. Med. 77,199 -205.[CrossRef][Web of Science][Medline]
Wang, T., Lacik, I., Brissova, M., Anilkumar, A.V., Prokop, A., Hunkeler, D., Green, R., Shahrokhi, K., and Powers, A.C. (1997) An encapsulation system for the immunoisolation of pancreatic islets. Nat. Biotechnol. 15,358 -362.[CrossRef][Web of Science][Medline]
Warnick, R.E. (2000) Phase III multicenter trial of GLI 328 HSV-TK gene therapy in newly diagnosed glioblastoma multiforme (GBM). Neuro-Oncology [serial online], Doc. 00-D226, September 21, 2000. URL: http://neuro-oncology.mc.duke.edu. Neuro-Oncology 2,300 . (Abstract)
Weber, C.J., Hagler, M., Konieczny, B., Chryssochoos, J., Rajotte, R., Lakkis, F., and Lowry, R. (1995) Encapsulated islet iso-, allo-, and xenografts in diabetic NOD mice. Transplant. Proc. 27,3308 -3311. (Abstract)[Web of Science][Medline]
Winn, S.R., Wahlberg, L., Tresco, P.A., and Aebischer, P. (1989) An encapsulated dopamine-releasing polymer alleviates experimental parkinsonism in rats. Exp. Neurol. 105,244 -250.[CrossRef][Web of Science][Medline]
Winn, S.R., Hammang, J.P., Emerich, D.F., Lee, A., Palmiter, R.D.,
and Baetge, E.E. (1994) Polymer-encapsulated cells genetically
modified to secrete human nerve growth factor promote the survival of
axotomized septal cholinergic neurons. Proc. Natl. Acad. Sci.
U.S.A. 91,2324
-2328.
Wu, Z.G., Shi, Z.Q., Lu, Z.N., Yang, H., Shi, F.Y., Zheng, X.R., and Sun, A.M. (1989) In vitro culture and transplantation of encapsulated human fetal islets as an artificial endocrine pancreas. ASAIO Trans. 35,736 -738.[Medline]
Zekorn, T., Siebers, U., Horcher, A., Schnettler, R., Klock, G., Bretzel, R.G., Zimmermann, U., and Federlin, K. (1992) Barium-alginate beads for immunoisolated transplantation of islets of Langerhans. Transplant. Proc. 24, 937-939. (Abstract)[Web of Science][Medline]
Zekorn, T.D., Horcher, A., Mellert, J., Siebers, U., Altug, T.A., Emre, A., Hahn, H.J., and Federlin, K. (1996) Biocompatibility and immunology in the encapsulation of islets of Langerhans (bioartificial pancreas). Int. J. Artif. Organs 19,251 -257.[Web of Science][Medline]
Zimmermann, U., Klock, G., Federlin, K., Hannig, K., Kowalski, M., Bretzel, R.G., Horcher, A., Entenmann, H., Sieber, U., and Zekorn, T. (1992) Production of mitogen-contamination free alginates with variable ratios of mannuronic acid to guluronic acid by free flow electrophoresis. Electrophoresis 13,269 -274.[CrossRef][Web of Science][Medline]
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. L. Willson, C. McElnea, J. Mariani, A. M. Lohof, and R. M. Sherrard BDNF increases homotypic olivocerebellar reinnervation and associated fine motor and cognitive skill Brain, April 1, 2008; 131(4): 1099 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Waxman and P. S. Schwartz Harnessing Apoptosis for Improved Anticancer Gene Therapy Cancer Res., December 15, 2003; 63(24): 8563 - 8572. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
